Three iTech research studies finished enrolling participants at the end of November 2021: COMPARE, LifeSteps PrEP for Youth, and ePrEP.
ATN 142: COMPARE is a follow-on study evaluating & comparing two distinct mobile apps, LYNX and MyChoices, designed to increase HIV testing and PrEP uptake in young men who have sex with men. The research study enrolled a total of 383 participants throughout the United States. Learn more about COMPARE here.
LifeSteps is an evidence-based HIV medication adherence intervention for individuals living with HIV developed by Safren et al. ATN 158: LifeSteps adapted this intervention for youth HIV prevention. The pilot randomized controlled trial (RCT) is assessing feasibility, acceptability and preliminary efficacy of the LSPY compared to standard of PrEP care only to improve PrEP adherence. LifeSteps enrolled a total of 32 participants in: Austin, TX; Connecticut; Durham, NH; Gary, IN; Georgia; Illinois; Massachusetts; Rhode Island. Learn more about LifeSteps PrEP for Youth here.
ATN 159: ePrEP is a home-care system for PrEP that allows men who have sex with men to initiate and maintain PrEP clinical care without requiring travel to a clinician office or to a laboratory for testing. ePrEP combines a home care system for behavioral surveillance and home specimen collection/shipping for laboratory tests with app-based telemedicine and patient management. ePrEP enrolled a total of 215 participants in Alabama, Georgia, Mississippi, and North Carolina. For more information about ePrEP click here.
Follow-ups with participants in each of these research studies will continue through May 2022. Look for more preliminary baseline information soon!